<SEC-DOCUMENT>0001415889-17-001484-index.html : 20170913
<SEC-HEADER>0001415889-17-001484.hdr.sgml : 20170913
<ACCEPTANCE-DATETIME>20170913182958
ACCESSION NUMBER:		0001415889-17-001484
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20170913
FILED AS OF DATE:		20170913
DATE AS OF CHANGE:		20170913

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Caribou Biosciences, Inc.
		CENTRAL INDEX KEY:			0001619856
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37766
		FILM NUMBER:		171084091

	BUSINESS ADDRESS:	
		STREET 1:		2929 7TH STREET, SUITE 105
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
		BUSINESS PHONE:		510-982-6030

	MAIL ADDRESS:	
		STREET 1:		2929 7TH STREET, SUITE 105
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Intellia Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001652130
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				364785571
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		40 ERIE STREET
		STREET 2:		SUITE 130
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
		BUSINESS PHONE:		857-285-6200

	MAIL ADDRESS:	
		STREET 1:		40 ERIE STREET
		STREET 2:		SUITE 130
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02139
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-09132017_030948.xml
<TEXT>
Document 1 - file: form4-09132017_030948.html

Document 1 - RAW XML: form4-09132017_030948.xml

</DOCUMENT>
</SEC-DOCUMENT>